META HEALTH LIMITED (SGX: 5DX)

META HEALTH LIMITED

SGX: 5DX (Meta Health)

Last update: 7 hours ago

0.005

0.00 (0.00%)

Add to watchlist

Previous Close	0.005
Open	0.004
Volume	100,200
Avg. Volume (3M)	379,160
Market Cap	6,601,950

Price / Sales	10.79
Price / Book	4.26

52 Weeks Range	0.004 (-20%) — 0.011 (119%)
Earnings Date	15 May 2025

Market Trend

		Short Term	Medium Term
Industry	Medical Care Facilities (SG)	Bearish	Mixed
	Medical Care Facilities (Global)	Mixed	Mixed
Stock	Meta Health	-	-

AIStockmoo Score

-1.0

Analyst Consensus	-2.0
Insider Activity	NA
Price Volatility	0.5
Technical Moving Averages	-2.5
Technical Oscillators	0.0
Average	-1.00

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
META HEALTH	7 M	-	-	4.26
SING PAINCARE	29 M	-	17.00	1.16
LIVINGSTONE	14 M	-	-	2.01
IHH	19 B	4.81%	23.22	2.01
RAFFLES MEDICAL	2 B	2.56%	32.50	1.73
THOMSON MEDICAL	1 B	-	-	2.18

Meta Health Ltd is a investment holding and engaged in healthcare business of telemedicine, nursing services and e-pharmacy. The Group’s only business unit, Healthcare business, operates mainly in Singapore and all noncurrent assets were located in Singapore.
Sector	Healthcare
Industry	Medical Care Facilities
Investment Style	Small Value
% Held by Insiders	34.12%

Ownership

Name	Date	Shares Held
Estate of Lin Wee, Daniel	06 Dec 2024	158,770,223 (15.03%)
GKL Investment Holdings Pte Ltd	18 Mar 2024	45,482,500 (4.31%)
Ng (Zhi Peng Robin)	18 Mar 2024	35,900,000 (3.40%)
Ng (Kee Huat Bernard)	29 Apr 2024	24,500,000 (2.32%)
Siaw (Ten Ten)	18 Mar 2024	19,809,600 (1.88%)

No data within this time range.

Date	Type	Details
22 May 2025	Announcement	General Announcement::Proposed Issue of 20,000,000 New Shares in Satisfaction of Performance Bonus Payable to Bernard Ng
22 May 2025	Announcement	Change - Announcement of Cessation::Resignation of Chief Medical Officer of the Company - Dr Bernard Ng Kee Huat
15 May 2025	Announcement	Financial Statements and Related Announcement::First Quarter Results
14 May 2025	Announcement	General Announcement::Minutes of Annual General Meeting Held on 28 April 2025
05 May 2025	Announcement	General Announcement::Lapse of Non-binding Term Sheet Relating to the Potential Acquisition of Aios Bio Sciences Pte. Ltd.
30 Apr 2025	Announcement	Annual Reports and Related Documents::
28 Apr 2025	Announcement	REPL::Annual General Meeting::Voluntary
17 Apr 2025	Announcement	General Announcement::Update on Breach of Settlement Agreement Involving Wholly-Owned Subsidiaries
11 Apr 2025	Announcement	Annual Reports and Related Documents::
11 Apr 2025	Announcement	Annual General Meeting::Voluntary
03 Apr 2025	Announcement	General Announcement::Update on Non-binding Term Sheet Relating to Potential Acquisition of Aios Bio Sciences Pte. Ltd.
03 Apr 2025	Announcement	Financial Statements and Related Announcement::Discrepancies between unaudited and audited accounts
03 Apr 2025	Announcement	Financial Statements and Related Announcement::Auditor's Comments of Accounts
21 Mar 2025	Announcement	General Announcement::Receipt of Demand for Payment From Dr Vasanthan Metupalle
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2025	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	-152.23%
Operating Margin (TTM)	-92.81%
Diluted EPS (TTM)	0.000
Quarterly Revenue Growth (YOY)	595.70%

Current Ratio (MRQ)	0.740
Operating Cash Flow (TTM)	-1.27 M
Levered Free Cash Flow (TTM)	1.76 M

Return on Assets (TTM)	-5.80%
Return on Equity (TTM)	-216.11%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)